Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer

被引:7
|
作者
Tomaszewska, Agata [1 ,2 ]
Roszak, Andrzej [3 ,4 ]
Pawlik, Piotr [5 ]
Sajdak, Stefan [5 ]
Jagodzinski, Pawel Piotr [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
[2] Poznan Univ Med Sci, Ctr Orthodont Miniimplants, Chair & Clin Maxillofacial Orthoped & Orthodont, PL-60781 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Electroradiol, PL-60781 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Radiotherapy & Gynecol Oncol, Poznan, Poland
[5] Poznan Univ Med Sci, Div Gynecol Surg, PL-60781 Poznan, Poland
关键词
HSD17B1; Cervical cancer; 17; beta-Estradiol; HUMAN-PAPILLOMAVIRUS TYPE-16; CELL-LINES; SQUAMOUS CARCINOGENESIS; ESTROGEN; EXPRESSION; ESTRADIOL; RISK; E6; 17-BETA-ESTRADIOL; DEHYDROGENASES;
D O I
10.1016/j.biopha.2015.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infections with oncogenic human papillomavirus (HPV) strains are recognized as the major risk factor for developing malignant lesions in the uterine cervix. However, several findings have demonstrated cooperation between HPV infection and 17 beta-estradiol (E2) in cervical carcinogenesis. The 17 beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) is the enzyme involved in the transformation of estrone (E1) into E2. In this study, we identified the HSD17B1 transcript and protein in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. These cells were able to convert E1 to E2 in a time-dependent manner. Moreover, we identified the HSD17B1 transcript and protein in primary cancerous tissues (n = 28) and in histologically unchanged tissues (n = 25). We did not observe significant differences (P = 0.33) between the HSD17B1 transcript levels in cancerous tissues and histologically unchanged tissues. However, we found an overrepresentation of the HSD17B1 protein in cancerous tissues compared with histologically unchanged tissues (P < 0.001). This overrepresentation of the HSD17B1 protein in primary cervical cancerous tissues may be responsible for the local conversion of E1 to E2. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [31] Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach
    Konings, Gonda F. J.
    Cornel, Karlijn M. C.
    Xanthoulea, Sofia
    Delvoux, Bert
    Skowron, Margaretha A.
    Kooreman, Loes
    Koskimies, Pasi
    Krakstad, Camilla
    Salvesen, Helga B.
    van Kuijk, Kim
    Schrooders, Yannick J. M.
    Vooijs, Marc
    Groot, Arjan J.
    Bongers, Marlies Y.
    Kruitwagen, Roy F. P. M.
    Romano, Andrea
    JOURNAL OF PATHOLOGY, 2018, 244 (02): : 203 - 214
  • [32] 17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production
    Aka, Juliette A.
    Mazumdar, Mausumi
    Chen, Chang-Qing
    Poirier, Donald
    Lin, Sheng-Xiang
    MOLECULAR ENDOCRINOLOGY, 2010, 24 (04) : 832 - 845
  • [33] Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
    Abdallah, BM
    Beck-Nielsen, H
    Gaster, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (10) : 627 - 634
  • [34] Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)
    He, Wanhong
    Gauri, Misra
    Li, Tang
    Wang, Ruixuan
    Lin, Sheng-Xiang
    GENE, 2016, 588 (01) : 54 - 61
  • [35] Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
    Spadaro, Alessandro
    Negri, Matthias
    Marchais-Oberwinkler, Sandrine
    Bey, Emmanuel
    Frotscher, Martin
    PLOS ONE, 2012, 7 (01):
  • [36] Multiple functions of type 10 17β-hydroxysteroid dehydrogenase
    Yang, SY
    He, XY
    Schulz, H
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (04): : 167 - 175
  • [37] 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
    Day, Joanna M.
    Foster, Paul A.
    Tutill, Helena J.
    Parsons, Michael F. C.
    Newman, Simon P.
    Chander, Surinder K.
    Allan, Gillian M.
    Lawrence, Harshani R.
    Vicker, Nigel
    Potter, Barry V. L.
    Reed, Michael J.
    Purohit, Atul
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (09) : 1931 - 1940
  • [38] Characterization of rat 17β-hydroxysteroid dehydrogenase type 1 gene and mRNA transcripts
    Akinola, LA
    Poutanen, M
    Peltoketo, H
    Vihko, R
    Vihko, P
    GENE, 1998, 208 (02) : 229 - 238
  • [39] Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions
    Delvoux, Bert
    D'Hooghe, Thomas
    Kyama, Cleophas
    Koskimies, Pasi
    Hermans, Rob J. J.
    Dunselman, Gerard A.
    Romano, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (01): : 276 - 284
  • [40] The 17beta-hydroxysteroid dehydrogenase type 1 gene polymorphism and endometriosis
    Mohammed, Mohammed Sayed
    Kamal, Hany Hassan
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2013, 5 (03) : 116 - 119